FDA Import Refusal 8QV-0065443-4/100001/1 — Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company

Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company — FEI 1719513

The FDA refused shipment 8QV-0065443-4/100001/1 from Insight Pharmaceuticals LLC, A Prestige Consumer Healthcare Company (United States) on Feb 3, 2026. The refused product falls under Drugs and Biologics — ANTI-FLATULENT N.E.C.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.